Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys
- 1 January 2006
- Vol. 24 (2) , 133-143
- https://doi.org/10.1016/j.vaccine.2005.07.067
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a Balanced, Broad, and Protective Neutralizing Antibody Response against Each of the Four Serotypes in Rhesus MonkeysJournal of Virology, 2005
- ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and EfficacyJournal of Virology, 2004
- Exchanging the Yellow Fever Virus Envelope Proteins with Modoc Virus prM and E Proteins Results in a Chimeric Virus That Is Neuroinvasive in SCID MiceJournal of Virology, 2004
- Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeysVaccine, 2003
- Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cellsVaccine, 2003
- Tick-Borne Langat/Mosquito-Borne Dengue Flavivirus Chimera, a Candidate Live Attenuated Vaccine for Protection against Disease Caused by Members of the Tick-Borne Encephalitis Virus Complex: Evaluation in Rhesus Monkeys and in MosquitoesJournal of Virology, 2001
- Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre studyVaccine, 1996
- Analysis of the structural protein gene sequence shows Kyasanur Forest disease virus as a distinct member in the tick-borne encephalitis virus serocomplexJournal of General Virology, 1994
- Nucleotide and deduced amino acid sequence of the envelope glycoprotein of Omsk haemorrhagic fever virus; comparison with other flavivirusesJournal of General Virology, 1993
- A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response studyVaccine, 1990